On February 23, 2021 Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, reported that members of its senior management team are scheduled to participate in three virtual investor conferences in March (Press release, Repare Therapeutics, FEB 23, 2021, View Source [SID1234575481]). Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Health Care Conference
Panel Discussion Title: Ovarian Cancer
Date: Tuesday, March 2, 2021
Time: 12:50 p.m. Eastern Time

H.C. Wainwright Annual Global Life Sciences Conference
Date: Tuesday, March 9 – Wednesday, March 10, 2021

Morgan Stanley Virtual Healthcare Corporate Access Day
Date: Tuesday, March 16, 2021

The prerecorded H.C. Wainwright presentation will be available on Tuesday, March 9, 2021, at 7:00 a.m. Eastern Time in the Investor section of the Company’s website at View Source A replay of the webcast will be archived on the Company’s website for 30 days.